These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4243437)

  • 1. [An allosteric enzyme with 2 substrates: phosphofructokinase from rat muscle. IV. Conjugated action of 2 allosteric inhibitors, ATP and citrate].
    Odeide R; Dupuis B; Guilloton M; Savany A; Rosenberg AJ
    Bull Soc Chim Biol (Paris); 1969 Dec; 51(7):1199-210. PubMed ID: 4243437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of an enzyme allosteric to 2 substrates: phosphofructokinases of rat muscle. II. Kinetic properties].
    Odeide R; Guilloton M; Dupuis B; Rosenberg AJ
    Bull Soc Chim Biol (Paris); 1968; 50(11):2035-52. PubMed ID: 4237773
    [No Abstract]   [Full Text] [Related]  

  • 3. [Actions and interactions of substrates and effectors of phosphofructokinase from rabbit skeletal muscle].
    Hofer HW; Pette D
    Hoppe Seylers Z Physiol Chem; 1968 Oct; 349(10):1378-92. PubMed ID: 4235316
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of an enzyme allosteric to 2 substrates: phosphofructokinase of rat muscle. I. Preparation and crystallization of the enzyme].
    Odeide R; Guilloton M; Dupuis B; Ravon D; Rosenberg AJ
    Bull Soc Chim Biol (Paris); 1968; 50(11):2023-33. PubMed ID: 4237772
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of an allosteric enzyme with 2 substates: phosphofructokinase from rat muscle. 3. Kinetic properties].
    Odeide R; Dupuis B; Guilloton M; Rosenberg AJ
    Bull Soc Chim Biol (Paris); 1969 Jun; 51(1):47-54. PubMed ID: 4241307
    [No Abstract]   [Full Text] [Related]  

  • 6. Allosteric properties of muscle phosphofructokinase. I. Binding of magnesium adenosine triphosphate to the inhibitory site.
    Kemp RG
    Biochemistry; 1969 Aug; 8(8):3162-8. PubMed ID: 4241302
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on heart phosphofructokinase. Desensitization of the enzyme to adenosine triphosphate inhibition.
    Ahlfors CE; Mansour TE
    J Biol Chem; 1969 Mar; 244(5):1247-51. PubMed ID: 4237418
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of phosphofructokinase by quinone methide and alpha-methylene lactone tumor inhibitors.
    Hanson RL; Lardy HA; Kupchan SM
    Science; 1970 Apr; 168(3929):378-80. PubMed ID: 4244949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of catalytic properties of muscle phosphofructokinase caused by association of enzymes].
    Hofer HW
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):685. PubMed ID: 4262619
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influencing of the catalytic properties of phosphofructokinase by chemical modification of functionally important amino acids].
    Hofer HW
    Hoppe Seylers Z Physiol Chem; 1970 May; 351(5):649-57. PubMed ID: 4245966
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of inhibitors with muscle phosphofructokinase.
    Colombo G; Tate PW; Girotti AW; Kemp RG
    J Biol Chem; 1975 Dec; 250(24):9404-12. PubMed ID: 127795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric properties of muscle phosphofructokinase. II. Kinetics of native and thiol-modified enzyme.
    Kemp RG
    Biochemistry; 1969 Nov; 8(11):4490-6. PubMed ID: 4242847
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on heart phosphofructokinase. Binding properties of native enzyme and of enzyme desensitized to allosteric control.
    Lorenson MY; Mansour TE
    J Biol Chem; 1969 Dec; 244(23):6420-31. PubMed ID: 4242924
    [No Abstract]   [Full Text] [Related]  

  • 14. Temperature effects on muscle phosphofructokinase of the Alaskan king crab, Paralithodes camtschatica.
    Freed JM
    Comp Biochem Physiol B; 1971 Aug; 39(4):765-74. PubMed ID: 4257182
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory properties of primate sperm phosphofructokinase.
    Hoskins DD; Stephens DT
    Biochim Biophys Acta; 1969 Nov; 191(2):292-302. PubMed ID: 4311146
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of the kinetic properties of phosphofructokinase by ammonium ions.
    Abrahams SL; Younathan ES
    J Biol Chem; 1971 Apr; 246(8):2464-7. PubMed ID: 4251852
    [No Abstract]   [Full Text] [Related]  

  • 17. Covalent modification of phosphofructokinase by phosphorylation--dephosphorylation.
    Söling HD; Brand IA
    Curr Top Cell Regul; 1981; 20():107-38. PubMed ID: 6276080
    [No Abstract]   [Full Text] [Related]  

  • 18. CITRATE INHIBITION OF PHOSPHOFRUCTOKINASE AND THE PASTEUR EFFECT.
    SALAS ML; VINUELA E; SALAS M; SOLS A
    Biochem Biophys Res Commun; 1965 Apr; 19():371-6. PubMed ID: 14317405
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of metabolites by phosphofructokinase.
    Kemp RG; Krebs EG
    Biochemistry; 1967 Feb; 6(2):423-34. PubMed ID: 4227735
    [No Abstract]   [Full Text] [Related]  

  • 20. Citrate inhibition of rat-kidney cortex phosphofructokinase.
    Sola MM; Oliver FJ; Salto R; Gutiérrez M; Vargas A
    Mol Cell Biochem; 1994 Jun; 135(2):123-8. PubMed ID: 7838139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.